Myeloid Cell-Derived HIF-1α Promotes Control of Leishmania major.
Valentin SchatzYannic StrüssmannAlexander MahnkeGunnar SchleyMaximilian WaldnerUwe RitterJens WildCarsten WillamNathalie DehneBernhard BrüneJennifer M McNiffOscar R ColegioChristian BogdanJonathan JantschPublished in: Journal of immunology (Baltimore, Md. : 1950) (2016)
Hypoxia-inducible factor-1α (HIF-1α), which accumulates in mammalian host organisms during infection, supports the defense against microbial pathogens. However, whether and to what extent HIF-1α expressed by myeloid cells contributes to the innate immune response against Leishmania major parasites is unknown. We observed that Leishmania-infected humans and L. major-infected C57BL/6 mice exhibited substantial amounts of HIF-1α in acute cutaneous lesions. In vitro, HIF-1α was required for leishmanicidal activity and high-level NO production by IFN-γ/LPS-activated macrophages. Mice deficient for HIF-1α in their myeloid cell compartment had a more severe clinical course of infection and increased parasite burden in the skin lesions compared with wild-type controls. These findings were paralleled by reduced expression of type 2 NO synthase by lesional CD11b+ cells. Together, these data illustrate that HIF-1α is required for optimal innate leishmanicidal immune responses and, thereby, contributes to the cure of cutaneous leishmaniasis.
Keyphrases
- immune response
- dendritic cells
- wild type
- endothelial cells
- bone marrow
- acute myeloid leukemia
- toll like receptor
- poor prognosis
- inflammatory response
- liver failure
- metabolic syndrome
- skeletal muscle
- big data
- antimicrobial resistance
- hepatitis b virus
- risk factors
- endoplasmic reticulum stress
- deep learning
- cell cycle arrest
- artificial intelligence
- trypanosoma cruzi